Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Treasury Shares (2021 - 2025)

Historic Treasury Shares for NeuroPace (NPCE) over the last 5 years, with Q3 2025 value amounting to $1.4 million.

  • NeuroPace's Treasury Shares fell 1538.11% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year decrease of 1538.11%. This contributed to the annual value of $1.5 million for FY2024, which is 3910.09% down from last year.
  • NeuroPace's Treasury Shares amounted to $1.4 million in Q3 2025, which was down 1538.11% from $1.6 million recorded in Q2 2025.
  • NeuroPace's 5-year Treasury Shares high stood at $5.3 million for Q1 2025, and its period low was $1282.0 during Q2 2024.
  • Over the past 5 years, NeuroPace's median Treasury Shares value was $1.6 million (recorded in 2024), while the average stood at $1.6 million.
  • Examining YoY changes over the last 5 years, NeuroPace's Treasury Shares showed a top increase of 16800977.61% in 2024 and a maximum decrease of 9995.72% in 2024.
  • Over the past 5 years, NeuroPace's Treasury Shares (Quarter) stood at $596085.0 in 2021, then surged by 194.62% to $1.8 million in 2022, then soared by 38.41% to $2.4 million in 2023, then crashed by 39.1% to $1.5 million in 2024, then decreased by 5.77% to $1.4 million in 2025.
  • Its last three reported values are $1.4 million in Q3 2025, $1.6 million for Q2 2025, and $5.3 million during Q1 2025.